期刊文献+

COX2促进卵巢癌细胞迁移及相关机制的研究 被引量:6

The effects and related mechanisms cyclooxygenase-2 act in the migration of ovarian cancer cells
下载PDF
导出
摘要 目的:探讨COX2对卵巢癌细胞株增殖及迁移的影响及其相关机制。方法:构建慢病毒载体Lenti-COX2-EGFP,转染卵巢癌细胞株SKOV3和ES2。PCR及Western blot法鉴定转染效率,CCK-8实验检测细胞增殖,划痕实验观察细胞迁移能力,qRTPCR法检测E-cadherin、Vimentin、Snail和Slug表达。结果:与对照组相比,过表达COX2后卵巢癌细胞的增殖和迁移能力增强,差异均有统计学意义(P<0.05);E-cadherin表达下调,Snail、Slug、Vimentin表达上调。COX2抑制剂塞来昔布处理则可抑制COX2过表达细胞的增殖及迁移能力,与对照组比较差异有统计学意义(P<0.05)。结论:COX2可促进卵巢癌细胞增殖及上皮间质转化(EMT)继而增强肿瘤细胞迁移能力;塞来昔布可发挥阻断作用。推测COX2可能是卵巢癌临床治疗的一个潜在靶点。 Objective: To examine whether COX2 could accelerate proliferation and metastases of ovarian cancer cells and its related mechanisms. Methods: We created LentiCOX2-EGFP and then transfected ovarian cancer cells. After that,we evaluated the effect of COX2 on proliferation and metastases of ovarian cancer via PCR,Western blot,qRT-PCR,CCK-8 test and healing test. Results: Compare with control group,after up-regulating COX2 expression,cell proliferation and migration accelerated. The expressions of Snail and Slug up-regulated,resulting in E-cadherin expression down-regulating and Vimentin expression up-regulating.Celecoxib can inhibit these affections. All of the differences were significant. Conclusion: COX2 can accelerate cell proliferation and EMT,which can accelerate migration. Celecoxib can inhibit this effect. So,COX2 may serve as a potential target for curing ovarian cancer.
机构地区 中日友好医院
出处 《现代妇产科进展》 CSCD 北大核心 2016年第8期561-565,共5页 Progress in Obstetrics and Gynecology
基金 国家自然科学基金资助项目(No:81372777 81372779)
关键词 卵巢癌 COX2 增殖 转移 EMT Ovarian cancer COX2 Proliferation Metastasis EMT
  • 相关文献

参考文献21

  • 1Zeisberg M,Neilson E.Biomarkers for epithelial-mesenchymal transitions.[J].J Clin Invest,2009,119(6):1429-1437.
  • 2Yang J,Weinberg R.Epithelial-Mesenchymal transition:at the crossroads of development and tumor metastasis[J].Dev Cell,2008,14(6):818-829.
  • 3Bocca C,Ievolella M,Autelli R,et al.Expression of Cox-2in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.[J].Expert Opin Therapeutic Targets,2014,18(2):121-135.
  • 4Buys SS,Partridge E,Black A,et al.Effect of screening on ovarian cancer mortality:the Prostate,Lung,Colorectal and Ovarian(PLCO)Cancer Screening Randomized Controlled Trial[J].JAMA,2013,5(22):2295-2303.
  • 5Ferrandina G,Lauriola L,Zannoni GF,et al.Increased cyclooxygenase-2(COX-2)expression is associated with chemotherapy resistance and outcome in ovarian cancer patients[J].Ann Oncol,2002,13(8):1205-1211.
  • 6邓琳,冯定庆,凌斌.环氧化酶2抑制剂抗卵巢癌作用的研究进展[J].现代妇产科进展,2015,24(11):876-878. 被引量:8
  • 7Giaginis C,Alexandrou P,Tsoukalas N,et al.Hu-antigen receptor(HuR)and cyclooxygenase-2(COX-2)expression in human non-small-cell lung carcinoma:associations with clinicopathological parameters,tumor proliferative capacity and patients'survival[J].Tumor Biol,2015,36(1):315-327.
  • 8Liu R,Zheng J,Li C,et al.Celecoxib induces epithelialmesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression[J].Arch Gynecol Obstet,2015,291:1361-1369.
  • 9Hu Z,Liu X,Tang Z,et al.Possible regulatory role of Snail in NF-κB-mediated changes in E-cadherin in gastric cancer[J].Oncol Rep,2013,29(3):993-1000.
  • 10Liang CM,Ho MY,Liang SM.COX-2/PGE2-driven lung cancer invasion/metastasis is dependent on MIG-7 and phosphorylated prohibitin[J].Cancer Res,2014,74(19Suppl):1056-1056.

二级参考文献3

共引文献7

同被引文献74

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部